| Michael Lindley, MD | |
|
15790 Paul Vega Md Dr, Hospital Medicine, Hammond, LA 70403-1434 | |
| (985) 230-3066 | |
| (985) 230-2072 |
| Full Name | Michael Lindley |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 15790 Paul Vega Md Dr, Hammond, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811216807 | NPI | - | NPPES |
| 2105281 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 205161 (Louisiana) | Primary |
| 207R00000X | Internal Medicine | 205161 (Louisiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Tammany Parish Hospital | Covington, LA | Hospital |
| West Jefferson Medical Center | Marrero, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Tammany Parish Hospital Service District No 1 | 0749273761 | 138 |
| New Orleans Physician Services Inc | 5294057824 | 124 |
News Archive
T cells from patients with melanoma can trigger a protective immune response against the disease according to a new study out of University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine.
Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.
Royal DSM N.V. has announced that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company.
Healthcare professionals at the Uniformed Services University of the Health Sciences' (USU) Center for the Study of Traumatic Stress (CSTS) have launched the "Courage to Care for Me" campaign as part of the "Courage to Care" initiative during April, the Month of the Military Child.
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.
› Verified 1 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
T cells from patients with melanoma can trigger a protective immune response against the disease according to a new study out of University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine.
Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.
Royal DSM N.V. has announced that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company.
Healthcare professionals at the Uniformed Services University of the Health Sciences' (USU) Center for the Study of Traumatic Stress (CSTS) have launched the "Courage to Care for Me" campaign as part of the "Courage to Care" initiative during April, the Month of the Military Child.
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.
› Verified 1 days ago
| Entity Name | St Tammany Parish Hospital Service District No 1 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598798597 PECOS PAC ID: 0749273761 Enrollment ID: O20051102000003 |
News Archive
T cells from patients with melanoma can trigger a protective immune response against the disease according to a new study out of University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine.
Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.
Royal DSM N.V. has announced that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company.
Healthcare professionals at the Uniformed Services University of the Health Sciences' (USU) Center for the Study of Traumatic Stress (CSTS) have launched the "Courage to Care for Me" campaign as part of the "Courage to Care" initiative during April, the Month of the Military Child.
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.
› Verified 1 days ago
| Entity Name | Belle Chasse Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245653237 PECOS PAC ID: 9335379379 Enrollment ID: O20140313000496 |
News Archive
T cells from patients with melanoma can trigger a protective immune response against the disease according to a new study out of University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine.
Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.
Royal DSM N.V. has announced that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company.
Healthcare professionals at the Uniformed Services University of the Health Sciences' (USU) Center for the Study of Traumatic Stress (CSTS) have launched the "Courage to Care for Me" campaign as part of the "Courage to Care" initiative during April, the Month of the Military Child.
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.
› Verified 1 days ago
| Entity Name | New Orleans Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396169678 PECOS PAC ID: 5294057824 Enrollment ID: O20141209002021 |
News Archive
T cells from patients with melanoma can trigger a protective immune response against the disease according to a new study out of University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine.
Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.
Royal DSM N.V. has announced that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company.
Healthcare professionals at the Uniformed Services University of the Health Sciences' (USU) Center for the Study of Traumatic Stress (CSTS) have launched the "Courage to Care for Me" campaign as part of the "Courage to Care" initiative during April, the Month of the Military Child.
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.
› Verified 1 days ago
| Entity Name | Signify Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689158487 PECOS PAC ID: 3274895263 Enrollment ID: O20210210001575 |
News Archive
T cells from patients with melanoma can trigger a protective immune response against the disease according to a new study out of University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine.
Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.
Royal DSM N.V. has announced that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company.
Healthcare professionals at the Uniformed Services University of the Health Sciences' (USU) Center for the Study of Traumatic Stress (CSTS) have launched the "Courage to Care for Me" campaign as part of the "Courage to Care" initiative during April, the Month of the Military Child.
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Lindley, MD Po Box 2666, Hospital Medicine, Hammond, LA 70404-2666 Ph: (985) 230-3066 | Michael Lindley, MD 15790 Paul Vega Md Dr, Hospital Medicine, Hammond, LA 70403-1434 Ph: (985) 230-3066 |
News Archive
T cells from patients with melanoma can trigger a protective immune response against the disease according to a new study out of University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine.
Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.
Royal DSM N.V. has announced that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company.
Healthcare professionals at the Uniformed Services University of the Health Sciences' (USU) Center for the Study of Traumatic Stress (CSTS) have launched the "Courage to Care for Me" campaign as part of the "Courage to Care" initiative during April, the Month of the Military Child.
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.
› Verified 1 days ago
Miss Rachel Ann Aaron, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 15790 Paul Vega Md Dr, Hammond, LA 70403 Phone: 985-230-1683 Fax: 985-230-2072 | |
Robert C. Peltier, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 15790 Paul Vega Md Dr, Hammond, LA 70403 Phone: 985-230-3668 Fax: 985-230-2072 |